EastGate Biotech

    OverviewSuggest Edit

    EastGate Biotech produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body. EastGate Biotech develops products in which the active components are incorporated into vehicles containing nano-sized delivery vectors, including: oil droplets (nanoemulsions), polymeric particles (nanoparticles), and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). 

    TypePublic
    Founded1999
    HQToronto, CA
    Websiteeastgatebiotech.com

    Latest Updates

    Employees (est.) (Dec 2016)2
    Revenue (FY, 2015)$132 K

    Key People/Management at EastGate Biotech

    Anna Gluskin

    Anna Gluskin

    CEO
    Rose Perri

    Rose Perri

    President
    Show more

    EastGate Biotech Office Locations

    EastGate Biotech has an office in Toronto
    Show all (1)

    EastGate Biotech Financials and Metrics

    EastGate Biotech Revenue

    EastGate Biotech's revenue was reported to be $132.03 k in FY, 2015
    USD

    Revenue (Q3, 2017)

    23.1k

    Gross profit (Q3, 2017)

    (69.2k)

    Gross profit margin (Q3, 2017), %

    (299.1%)

    Net income (Q3, 2017)

    (1.6m)

    Cash (31-Mar-2017)

    9.3k
    Annual
    USDFY, 2014FY, 2015FY, 2016

    Revenue

    132.0k

    Cost of goods sold

    19.2k

    Gross profit

    112.8k

    Gross profit Margin, %

    85%
    Quarterly
    USDQ3, 2013Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Revenue

    73.2k1.1k114.5k23.1k

    Cost of goods sold

    11.1k56.9k92.3k

    Gross profit

    62.1k57.6k(69.2k)

    Gross profit Margin, %

    85%50%(299%)
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Cash

    458.0286.5k19.2k

    Current Assets

    458.0339.7k113.5k

    Total Assets

    71.8k482.9k297.9k

    Accounts Payable

    421.4k14.6k
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

    Cash

    26.4k784.0k375.3k10.8k72.5k9.3k

    Accounts Receivable

    36.0k

    Current Assets

    26.4k784.0k375.3k166.8k734.0k72.5k9.3k

    Total Assets

    101.8k865.8k529.1k364.7k904.8k72.5k9.3k
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    (4.9m)(4.3m)(3.0m)

    Depreciation and Amortization

    14.5k27.9k44.2k

    Accounts Payable

    192.2k47.4k100.0k18.9k

    Cash From Operating Activities

    (407.7k)
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2015Q1, 2016Q2, 2016Q3, 2016

    Net Income

    (636.2k)(2.9m)(3.5m)(697.7k)(1.9m)(2.4m)

    Depreciation and Amortization

    10.5k4.3k9.6k30.7k13.6k

    Accounts Payable

    189.8k(83.0k)(91.9k)67.5k(15.1k)2.0k(7.4k)

    Cash From Operating Activities

    (231.8k)(412.9k)(550.1k)(103.5k)(113.7k)
    Show all financial metrics

    EastGate Biotech Online and Social Media Presence

    Embed Graph

    EastGate Biotech News and Updates

    EastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 Diabetes Patients

    Multi-Center Phase III Trial Planned for 2019West Caldwell, NJ and Toronto, Canada - (NewMediaWire) - May 15, 2019 - EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company, that focuses on innovative technological developments specifically in insulin drug delivery for the treatment …

    EastGate Biotech Announces Positive Phase II Clinical Results of its Innovative Liquid Insulin Mouth Rinse Solution for Type 2 Diabetes

    Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a dayWest Caldwell, NJ and Toronto, Canada - (NewMediaWire) - April 24, 2019 - EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company, that focuses on inn…

    EastGate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply

    Alliance with MJ Biopharm of Mumbai, India positions the company to further its plans for SEA countries for its liquid insulin mouth rinseWest Caldwell, NJ and Toronto, Canada - (NewMediaWire) - March 19, 2019 - EastGate Biotech Corp. (OTC PINK: ETBI),  a pharmaceutical company that focuses on …

    EastGate Biotech Attends Arab Health Conference Seeking Additional Joint Venture Partnerships

    EastGate Biotech to Showcase Insulin Products at the Dubai World Trade CentreWest Caldwell, NJ and Toronto, Canada - (NewMediaWire) - January 30, 2019 - via NEWMEDIAWIRE -- EastGate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments s…

    EastGate Biotech Appoints World-Renowned Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives

    Key Opinion Leader spreading awareness of diabetes endorses the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients

    EastGate Biotech Receives Approval to Commence a Phase 2 Trial for Liquid Insulin Mouth Rinse Solution Addressing Patient Compliance in the Type 2 Diabetes Market

    DRAP (Drug Regulatory Authority Pakistan) provided approval to commence studies of INSUGIN in Pakistan

    EastGate Biotech Blogs

    Link to interview with Ms. Anna Gluskin, CEO, Eastgate Biotech Corp. on Wall Street Analyzer

    Link to the interview of Eastgate's CEO Ms. Anna Gluskin....

    Eastgate BioTech Corp (OTCBB: ETBI) Interview with CEO Anna Gluskin

    Eastgate BioTech Corp (OTCBB: ETBI) Interview with CEO Anna Gluskin...

    https://upticknewswire.com/interview-ceo-anna-gluskin-of-eastgate-biotech-corp-otc-etbi/

    Interview: CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI)...

    Eastgate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply

    Alliance with MJ Biopharm of Mumbai, India positions the company to further its plans for SEA countries for its liquid insulin mouth rinse...

    EastGate Biotech Attends Arab Health Conference Seeking Additional Joint Venture Partnerships

    EastGate Biotech to Showcase Insulin Products at the Dubai World Trade Centre...
    Show more

    EastGate Biotech Frequently Asked Questions

    • When was EastGate Biotech founded?

      EastGate Biotech was founded in 1999.

    • Who are EastGate Biotech key executives?

      EastGate Biotech's key executives are Anna Gluskin and Rose Perri.

    • How many employees does EastGate Biotech have?

      EastGate Biotech has 2 employees.

    • Who are EastGate Biotech competitors?

      Competitors of EastGate Biotech include Natural Alternatives International, Zivo Bioscience and 024 Pharma.

    • Where are EastGate Biotech offices?

      EastGate Biotech has an office in Toronto.

    • How many offices does EastGate Biotech have?

      EastGate Biotech has 1 office.